Granahan Investment Management, LLC Jounce Therapeutics, Inc. Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.01 - $8.54 $1.01 Million - $1.44 Million	-168,424 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.11 - $9.64 $40,889 - $55,439	-5,751 Reduced 3.3%	168,424 $1.41 Million
Q3 2021 Nov 15, 2021	SELL	$5.04 - $8.73 $925,555 - $1.6 Million	-183,642 Reduced 51.32%	174,175 $1.29 Million
Q2 2021 Aug 16, 2021	BUY	$6.58 - $10.66 $124,019 - $200,919	18,848 Added 5.56%	357,817 $2.43 Million
Q1 2021 May 17, 2021	SELL	$6.73 - $13.87 $410,826 - $846,680	-61,044 Reduced 15.26%	338,969 $3.48 Million
Q4 2020 Feb 12, 2021	SELL	$6.37 - $10.33 $456,149 - $739,720	-71,609 Reduced 15.18%	400,013 $2.8 Million
Q3 2020 Nov 12, 2020	SELL	$4.58 - $10.95 $202,097 - $483,179	-44,126 Reduced 8.56%	471,622 $3.85 Million
Q2 2020 Aug 14, 2020	BUY	$4.17 - $7.58 $1.05 Million - $1.91 Million	251,609 Added 95.26%	515,748 $3.56 Million
Q1 2020 May 12, 2020	BUY	$2.91 - $8.7 $412,803 - $1.23 Million	141,857 Added 116.01%	264,139 $1.26 Million
Q4 2019 Feb 14, 2020	SELL	$2.81 - $9.21 $1,770 - $5,802	-630 Reduced 0.51%	122,282 $1.07 Million
Q3 2019 Nov 15, 2019	BUY	$3.33 - $4.93 $22,750 - $33,681	6,832 Added 5.89%	122,912 $409,000
Q2 2019 Aug 14, 2019	SELL	$4.3 - $6.73 $40,647 - $63,618	-9,453 Reduced 7.53%	116,080 $575,000
Q1 2019 May 14, 2019	SELL	$3.43 - $6.87 $20,099 - $40,258	-5,860 Reduced 4.46%	125,533 $778,000
Q4 2018 Feb 13, 2019	SELL	$2.69 - $6.71 $10,456 - $26,081	-3,887 Reduced 2.87%	131,393 $443,000
Q3 2018 Nov 13, 2018	BUY	$6.5 - $8.37 $23,972 - $30,868	3,688 Added 2.8%	135,280 $879,000
Q2 2018 Aug 15, 2018	BUY	$7.27 - $21.88 $80,020 - $240,833	11,007 Added 9.13%	131,592 $1.01 Million
Q1 2018 May 14, 2018	BUY	$13.4 - $28.4 $33,835 - $71,710	2,525 Added 2.14%	120,585 $2.7 Million
Q4 2017 Feb 12, 2018	BUY	$12.52 - $17.82 $1.48 Million - $2.1 Million	118,060	118,060 $1.51 Million

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account